Compare · ZBH vs ZY
ZBH vs ZY
Side-by-side comparison of Zimmer Biomet Holdings Inc. (ZBH) and Zymergen Inc. (ZY): market cap, price performance, sector, and recent activity on the wire.
Summary
- ZBH operates in Health Care, while ZY operates in Industrials - the two are in different parts of the market.
- ZBH is the larger of the two at $25.25B, about 51.7x ZY ($488.5M).
- ZBH has hit the wire 2 times in the past 4 weeks while ZY has been quiet.
- ZBH has more recent analyst coverage (25 ratings vs 13 for ZY).
- Company
- Zimmer Biomet Holdings Inc.
- Zymergen Inc.
- Price
- $91.33-1.18%
- $2.44+2.10%
- Market cap
- $25.25B
- $488.5M
- 1M return
- +4.25%
- -
- 1Y return
- -10.23%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 25
- 13
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Zymergen Inc.
Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.
Latest ZBH
- Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results
- Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
- SEC Form 4 filed by Noor Jehanzeb
- SEC Form 4 filed by Jafry Syed A.
- SEC Form 4 filed by Kolli Sreelakshmi
- SEC Form 4 filed by Shapiro Louis
- SEC Form 4 filed by Hilado Maria Teresa
- SEC Form 4 filed by Higgins Arthur J
- SEC Form 4 filed by Kurdikar Devdatt
- SEC Form 4 filed by Hagemann Robert
Latest ZY
- SEC Form 15-12G filed by Zymergen Inc.
- SEC Form EFFECT filed by Zymergen Inc.
- SEC Form SC 13G/A filed by Zymergen Inc. (Amendment)
- SEC Form 4: Svf Excalibur (Cayman) Ltd disposed of 26,614,219 shares
- SEC Form 4: Flatley Jay T returned 144,789 shares to the company, closing all direct ownership in the company
- SEC Form 4: Chu Steven returned 50,000 shares to the company, closing all direct ownership in the company
- SEC Form 4: Peterson Sandra E returned 119,119 shares to the company, closing all direct ownership in the company
- SEC Form 4: Murdoch Travis returned 79,697 shares to the company, closing all direct ownership in the company
- SEC Form 4: Gorjanc Christine Marie returned 50,000 shares to the company, closing all direct ownership in the company
- SEC Form 4 filed by Sharma Rohit